PropertyValue
?:definition
  • Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., serum) to determine anti-Ri antibodies; these antibodies are found in patients with diseases characterized by an association between neurological disorders and cancer in the absence of metastatic, infectious, or metabolic complications (i.e., paraneoplastic neurological diseases). Reagents to determine anti-Ri antibodies may be used in assays intended for early diagnosis of cancer.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3690617_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3690617_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all